Are Medplus Health latest results good or bad?
Medplus Health's latest results are mixed; while Profit Before Tax and Profit After Tax saw significant increases, Net Sales declined and concerns arose over reliance on non-operating income. Overall, the company shows improved profitability but faces challenges in sales growth.
Medplus Health Services has reported its financial results for the quarter ending March 2025, highlighting several operational trends. The Profit Before Tax (PBT) reached Rs 45.33 crore, reflecting a growth of 63.5% compared to the average PBT of Rs 27.72 crore over the previous four quarters. The Profit After Tax (PAT) stood at Rs 51.34 crore, marking a 55.1% increase from the average PAT of Rs 33.10 crore in the prior quarters. The operating profit also showed a notable rise, with the Operating Profit (PBDIT) hitting Rs 136.38 crore, the highest in the last five quarters, and the Operating Profit Margin improved to 9.03%, indicating enhanced operational efficiency. Additionally, the Earnings per Share (EPS) reached Rs 4.29, the highest in the last five quarters, suggesting increased profitability for shareholders.
However, it is important to note that the company experienced a decline in Net Sales, with a QoQ growth of -3.32% compared to -0.93% in the previous quarter. The consolidated Net Profit also showed a QoQ growth of 11.88%, down from 18.46% in the prior quarter. Furthermore, there was a rise in Non-Operating Income, which reached Rs 15.79 crore, the highest in the last five quarters, potentially raising concerns about the sustainability of income derived from non-business activities.
Overall, Medplus Health has seen an adjustment in its evaluation over the last three months.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
